Agrimoniin and Erlotinib Inhibit Pancreatic Cancer Growth in Preclinical Study
In preclinical models, combining agrimoniin with erlotinib inhibited pancreatic cancer cell proliferation by altering tumor microenvironment signaling and disrupting metabolic ...

